<code id='DDDB94B166'></code><style id='DDDB94B166'></style>
    • <acronym id='DDDB94B166'></acronym>
      <center id='DDDB94B166'><center id='DDDB94B166'><tfoot id='DDDB94B166'></tfoot></center><abbr id='DDDB94B166'><dir id='DDDB94B166'><tfoot id='DDDB94B166'></tfoot><noframes id='DDDB94B166'>

    • <optgroup id='DDDB94B166'><strike id='DDDB94B166'><sup id='DDDB94B166'></sup></strike><code id='DDDB94B166'></code></optgroup>
        1. <b id='DDDB94B166'><label id='DDDB94B166'><select id='DDDB94B166'><dt id='DDDB94B166'><span id='DDDB94B166'></span></dt></select></label></b><u id='DDDB94B166'></u>
          <i id='DDDB94B166'><strike id='DDDB94B166'><tt id='DDDB94B166'><pre id='DDDB94B166'></pre></tt></strike></i>

          
          WSS
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Leave your comment

          Please enter your name
          Please enter your comment

          fashion